| Kennon Miller, MD | |
|
450 Veterans Memorial Pkwy, Building 14, E Providence, RI 02914-5300 | |
| (401) 435-6600 | |
| Not Available |
| Full Name | Kennon Miller |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 37 Years |
| Location | 450 Veterans Memorial Pkwy, E Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689786725 | NPI | - | NPPES |
| 27549 | Other | RI | BLUE SHIELD |
| 9003513 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD11459 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Miriam Hospital | Providence, RI | Hospital |
| Rhode Island Hospital | Providence, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brown Urology, Inc. | 7810254513 | 30 |
News Archive
A joint panel of experts from the Society for Healthcare Epidemiology and the Infectious Diseases Society of America today released online new clinical practice guidelines for Clostridium difficile infection in adults. The guidelines, to be published in the May issue of Infection Control and Hospital Epidemiology, update recommendations regarding the epidemiology, diagnosis, treatment and infection control and environmental management of this disease.
For the third consecutive year, U.S. News & World Report named Hospital for Special Surgery the top hospital in the country for orthopedics in its 2012 "America's Best Hospitals" survey. Once again, the hospital ranked as a leader in rheumatology at number three in the nation. In addition, neurology was ranked at No. 10.
In a retrospective study of trauma patients over 65 years of age attended by KSS, it was found that, although a number of these patients had sustained a minor injury through seemingly innocuous mechanisms, a high proportion of this group required advanced clinical interventions and subsequent tertiary level care at a major trauma center.
Sanofi-Aventis Deutschland GmbH and Novalar Pharmaceuticals, Inc. today announced that the Marketing Authorization Application (MAA) for OraVerse has been accepted for review by the regulatory agencies of the United Kingdom (UK), Germany, Italy, France and Spain. OraVerse is the first and only local anesthesia reversal agent that accelerates the return of normal sensation and function following routine dental procedures. OraVerse is approved for use in the U.S. by the Food and Drug Administration and sold by Novalar direct to U.S. dentists.
Communication between the brain's auditory and reward circuits is the reason why humans find music rewarding, according to new research published in JNeurosci.
› Verified 2 days ago
| Entity Name | Brown Urology, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467973099 PECOS PAC ID: 7810254513 Enrollment ID: O20171206000082 |
News Archive
A joint panel of experts from the Society for Healthcare Epidemiology and the Infectious Diseases Society of America today released online new clinical practice guidelines for Clostridium difficile infection in adults. The guidelines, to be published in the May issue of Infection Control and Hospital Epidemiology, update recommendations regarding the epidemiology, diagnosis, treatment and infection control and environmental management of this disease.
For the third consecutive year, U.S. News & World Report named Hospital for Special Surgery the top hospital in the country for orthopedics in its 2012 "America's Best Hospitals" survey. Once again, the hospital ranked as a leader in rheumatology at number three in the nation. In addition, neurology was ranked at No. 10.
In a retrospective study of trauma patients over 65 years of age attended by KSS, it was found that, although a number of these patients had sustained a minor injury through seemingly innocuous mechanisms, a high proportion of this group required advanced clinical interventions and subsequent tertiary level care at a major trauma center.
Sanofi-Aventis Deutschland GmbH and Novalar Pharmaceuticals, Inc. today announced that the Marketing Authorization Application (MAA) for OraVerse has been accepted for review by the regulatory agencies of the United Kingdom (UK), Germany, Italy, France and Spain. OraVerse is the first and only local anesthesia reversal agent that accelerates the return of normal sensation and function following routine dental procedures. OraVerse is approved for use in the U.S. by the Food and Drug Administration and sold by Novalar direct to U.S. dentists.
Communication between the brain's auditory and reward circuits is the reason why humans find music rewarding, according to new research published in JNeurosci.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kennon Miller, MD 144 Woodbury St, Providence, RI 02906-3546 Ph: (401) 435-6600 | Kennon Miller, MD 450 Veterans Memorial Pkwy, Building 14, E Providence, RI 02914-5300 Ph: (401) 435-6600 |
News Archive
A joint panel of experts from the Society for Healthcare Epidemiology and the Infectious Diseases Society of America today released online new clinical practice guidelines for Clostridium difficile infection in adults. The guidelines, to be published in the May issue of Infection Control and Hospital Epidemiology, update recommendations regarding the epidemiology, diagnosis, treatment and infection control and environmental management of this disease.
For the third consecutive year, U.S. News & World Report named Hospital for Special Surgery the top hospital in the country for orthopedics in its 2012 "America's Best Hospitals" survey. Once again, the hospital ranked as a leader in rheumatology at number three in the nation. In addition, neurology was ranked at No. 10.
In a retrospective study of trauma patients over 65 years of age attended by KSS, it was found that, although a number of these patients had sustained a minor injury through seemingly innocuous mechanisms, a high proportion of this group required advanced clinical interventions and subsequent tertiary level care at a major trauma center.
Sanofi-Aventis Deutschland GmbH and Novalar Pharmaceuticals, Inc. today announced that the Marketing Authorization Application (MAA) for OraVerse has been accepted for review by the regulatory agencies of the United Kingdom (UK), Germany, Italy, France and Spain. OraVerse is the first and only local anesthesia reversal agent that accelerates the return of normal sensation and function following routine dental procedures. OraVerse is approved for use in the U.S. by the Food and Drug Administration and sold by Novalar direct to U.S. dentists.
Communication between the brain's auditory and reward circuits is the reason why humans find music rewarding, according to new research published in JNeurosci.
› Verified 2 days ago
Rashmi S Licht, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 450 Veterans Memorial Pkwy, Building 14, E Providence, RI 02914 Phone: 401-435-6600 | |
Eric Bradley Miller, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 450 Veterans Memorial Pkwy, Building 14, E Providence, RI 02914 Phone: 401-435-6600 | |
Bernard A Moule, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 450 Veterans Memorial Pkwy, Building 14, E Providence, RI 02914 Phone: 401-435-6600 |